GAS5 and breast cancer: As GAS5 expression is significantly higher in patients with breast cancer carrying the rs145204276 ins/del and del/del genotypes versus the rs145204276 ins/ins genotype carriers, and since the rs145204276 del allele increases the transcription of GAS5, this polymorphism may affect the risk of breast cancer by modulating GAS5 expression levels [109].